XERS icon

Xeris Biopharma Holdings
XERS

Upgrade to unlock
Buy
Hold
Sell

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$11.25
50% upside
High target

4 analyst ratings

positive
1  neutral
25%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Brandon Folkes
67% 1-yr XERS win rate
9 Jan ‘26 8 days ago
Barclays
Barclays
Glen Santangelo
100% 1-yr XERS win rate
9 Dec ‘25 1 month ago
Oppenheimer
Oppenheimer
Leland Gershell
50% 1-yr XERS win rate
7 Nov ‘25 2 months ago
Piper Sandler
Piper Sandler
David Amsellem
7 Nov ‘25 2 months ago